CGAS and cancer: Activation of cGAS-STING signaling has also been recognized to mediate systemic tumor rejection by combined RT and checkpoint blockade given that knockdown of cGAS and STING in cancer cells abrogated priming of CD8+ T-cells in tumor-draining sites and infiltration of abscopal tumors by CD8+ T-cells [89].